Atossa Therapeutics Ownership | Who Owns Atossa Therapeutics?


OverviewForecastFinancialsChart

Atossa Therapeutics Ownership Summary


Atossa Therapeutics is owned by 14.38% institutional investors, 1.41% insiders, and 84.22% retail investors. Blackrock is the largest institutional shareholder, holding 7.34% of ATOS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.05% of its assets in Atossa Therapeutics shares.

ATOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtossa Therapeutics14.38%1.41%84.22%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock9.20M7.34%$10.94M
Vanguard group6.15M4.76%$3.63M
Vanguard fiduciary trust52.23K0.61%$274.76K
Nuveen asset management170.73K0.14%$161.19K
Bank of america corp /de/105.67K0.08%$125.75K
Vanguard global advisers3.09K0.04%$16.25K
Point72 asia (singapore) pte.44.11K0.03%$38.24K
Wolverine trading18.34K0.01%$16.01K
Greenberg financial group18.22K0.01%$10.75M
Alliancebernstein17.38K0.01%$16.41K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Point72 asia (singapore) pte.44.11K0.01%$38.24K
Greenberg financial group18.22K0.00%$10.75M
Planning capital management1.00K0.00%$1.19K
Northrock partners16.75K0.00%$14.52K
Blackrock9.20M0.00%$10.94M
Avion wealth318.000.00%$1.00K
Jain global16.71K0.00%$14.48K
Unique wealth strategies166.000.00%$299.00
Vanguard group6.15M0.00%$3.63M
Vanguard fiduciary trust52.23K0.00%$274.76K

Top Buyers

HolderShares% AssetsChange
Blackrock9.20M0.00%6.45M
Vanguard group6.15M0.00%68.99K
Vanguard fiduciary trust52.23K0.00%52.23K
Bank of america corp /de/105.67K-25.74K
Greenberg financial group18.22K0.00%18.22K

Top Sellers

HolderShares% AssetsChange
Ameriprise financial---3.79M
Laurion capital management lp---2.23M
Renaissance---2.06M
Blackrock funding, inc. /de---2.00M
Geode capital management---1.37M

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust52.23K0.00%52.23K$274.76K
Greenberg financial group18.22K0.00%18.22K$10.75M
Vanguard global advisers3.09K-3.09K$16.25K
Planning capital management1.00K0.00%1.00K$1.19K
Avion wealth318.000.00%318.00$1.00K

Sold Out

HolderChange
Eversource wealth advisors-2.00
Larson financial group-20.00
Capital performance advisors llp-25.00
True wealth design-29.00
Srs capital advisors-42.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202632-52.24%1,239,476-94.35%144.98%9-71.88%23155.56%
Dec 31, 202518-74.29%6,781,735-65.01%52.33%7-65.00%2-92.00%
Sep 30, 202520-76.74%6,698,329-68.63%51.90%6-85.00%3-88.00%
Jun 30, 202586-21,349,077-24.72%163.43%3944.44%25-19.35%
Mar 31, 202586-1.15%28,358,791-5.26%213.88%27-32.50%3147.62%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.94M3.05%-
Vanguard Total Stock Mkt Idx Inv256.14K2.97%-
iShares Russell 2000 ETF3.15M2.44%-
Columbia Small Cap Value Discovery Fund189.23K2.20%7.61K
Columbia Small Cap Value Discv A2.75M2.13%2.75M
Columbia Small Cap Value I A2.09M1.62%57.50K
Columbia Small Cap Value I2.04M1.58%2.04M
Vanguard Institutional Extnd Mkt Idx Tr99.42K1.15%13.00K
Fidelity Small Cap Index1.29M1.00%-
iShares Russell 2000 Value ETF1.01M0.78%-

Recent Insider Transactions


DateNameRoleActivityValue
May 21, 2025QUAY STEVEN C President & CEOBuy$9.89K
Mar 26, 2025Remmel H. Lawrence-Buy$7.00K
Apr 10, 2024Finn Jonathan-Buy$44.25K
Nov 15, 2023WEAVER GREGORY L Former EVP, CFO, & DirectorSell$32.50K
Jun 20, 2023WEAVER GREGORY L EVP & CFOBuy$48.50K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4--
2025 Q21-
2025 Q11-

ATOS Ownership FAQ


Who Owns Atossa Therapeutics?

Atossa Therapeutics shareholders are primarily institutional investors at 14.38%, followed by 1.41% insiders and 84.21% retail investors. The average institutional ownership in Atossa Therapeutics's industry, Biotech Stocks , is 35.75%, which Atossa Therapeutics falls below.

Who owns the most shares of Atossa Therapeutics?

Atossa Therapeutics’s largest shareholders are Blackrock (9.2M shares, 7.34%), Vanguard group (6.15M shares, 4.76%), and Vanguard fiduciary trust (52.24K shares, 0.61%). Together, they hold 12.70% of Atossa Therapeutics’s total shares outstanding.

Does Blackrock own Atossa Therapeutics?

Yes, BlackRock owns 7.34% of Atossa Therapeutics, totaling 9.2M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 10.94M$. In the last quarter, BlackRock increased its holdings by 6.45M shares, a 234.28% change.

Who is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested?

Point72 asia (singapore) pte is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 44.11K Atossa Therapeutics shares, valued at 38.24K$.

Who is the top mutual fund holder of Atossa Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atossa Therapeutics shares, with 3.05% of its total shares outstanding invested in 3.94M Atossa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools